Effect of sweet almond oil on survival rate and plasma cholinesterase activity of aluminum phosphide-intoxicated rats

Abstract

Introduction: Aluminum phosphide (ALP), as an effective pesticide and a substance used for protecting rice during storage, has become one of the commonest causes of poisoning and even suicide in developing countries including Iran and India. The authors aimed to study the efficacy of sweet almond oil as an antidote in ALP toxicity. Methods: The present experimental study was conducted over 35 rats. The animals were divided into four groups: one group as the control group and three other groups which received ALP alone or ALP and sweet almond oil with different time intervals. In addition to estimating the survival rate of the animals, plasma cholinesterase activity as a possible factor affected in ALP poisoning was evaluated. Results: Treatment by intragastric irrigation of sweet almond oil resulted in significant reduction of mortality. Moreover, mean plasma cholinesterase levels were inhibited in groups receiving ALP. Conclusion: Oral sweet almond oil, if especially used immediately after poisoning with ALP, improves the survival rate.

Keywords

aluminum phosphide poisoning sweet almond oil plasma cholinesterase

Introduction

Aluminum phosphide (ALP) is a solid pesticide commonly applied for preserving rice and grain. In Iran it is known as the rice tablet which is cheap and highly toxic.¹ After exposure to moisture it releases phosphine gas (PH3), the active pesticide component with garlic-like odor, which is immediately absorbed through inhalation, ingestion or contact. With oral intake, the phosphine gas released is absorbed by the gastrointestinal tract by simple diffusion and is mainly excreted by the kidneys and lungs.^1,2 This gas is thought to have the central role in mechanism of ALP toxicity as it inhibits cytochrome c oxidase.³ There are many reports of serious phosphide poisoning including fatalities from India and other developing countries.^4,5 For example, for a decade it has become the most common chemical for unintentional poisoning in India.^6

–9 In a study of 217 poisoned children in Northern India, 58% of all ALP-intoxicated patients died and this agent accounted for 62% of all deaths.¹⁰ It is a rare way for suicide except in Iran and Jordan from where a few case series have been reported.^11,12 In a retrospective 7-year study of ALP poisoning in Tehran, 471 patients were admitted to a referral hospital with ALP poisoning. In that study, the overall case fatality ratio was 31%.¹³ Deaths which usually occur within 12–24 hours are secondary to peripheral vascular collapse, cardiac failure and adult respiratory distress syndrome (ARDS). Inhibition of plasma cholinesterase activity and also methemoglobinemia has been reported from animal studies in acute ALP poisoning.^14

–18 By diminution of oxidant stress caused by phosphine, trimetazidine is used for the treatment of cardiac toxicity.¹⁸ Some animal studies have suggested increased survival time with the use of N-acetylcysteine and pralidoxime.^15,19 There is no antidote to phosphine or ALP poisoning and a great majority of patients die despite intensive care. Thus, supportive measures are all that can be offered.²⁰ In vitro experiments revealed that vegetable oils can inhibit the release of phosphine from ALP.²¹ Non availability of specific antidote, and also limitation of supportive care strategies have been our reasons for conducting the present study. In this study the effect of sweet almond oil on ALP toxicity was evaluated and compared with control group in an animal model. Consistent with the management protocols of patients with toxicological emergencies, there is a necessity to study various diagnostic and ancillary tests; therefore, the plasma activity of cholinesterase was analyzed to evaluate the efficacy of intervention.

Methods

Experimental

Adult Wistar strain rats (n = 35) of either sex were purchased from a private animal house, all weighing between 200 and 250 grams. They were acclimatized for 1 week under controlled conditions in which a 12 h/12 h light/dark cycle was maintained in a temporary animal house with access to food and water ad libitum. The experiments performed in this study have been carried out according to the World Medical Association statement on animal use in biomedical research.²² Exposure to ALP and experiments assessing the effects of ALP on rats were carried out in a separate, isolated laboratory under the same environmental condition as the colony room. The animals were divided into four groups: group 1 (control group, n = 5; saline treated, intragastric [IG]), group 2 (n = 10; ALP exposed, 11.5 mg/kg ALP, IG), group 3 (n = 10; ALP exposed, 11.5 mg/kg ALP + 10 ml sweet almond oil, IG) and group 4 (n = 10; ALP exposed, 11.5 mg/kg ALP + 10 ml sweet almond oil 30 min later, IG). The rats in group 1 were sham operated and saline treated. In groups 2–4, rats were monitored for survival times. The animals were fasted overnight with free access to water before experiment. In all animals, anesthesia was induced by injecting pentobarbital (30 mg/kg, intraperitoneal) then a vertical incision was made over epigastrium. By exposing the stomach, stomach was occluded by knotting suture material around its upper portion and powdered ALP in normal saline was administered into the stomach through a catheter. In group 3, 10 ml sweet almond oil was administered immediately, and after withdrawal of catheter, gastrostomy hole was closed by tightening sutures. In group 4 the same steps were repeated, except that nelaton catheter was hold in place by purse suture followed by sweet almond oil administration 30 minutes later. Besides measuring plasma cholinesterase in control group, plasma cholinesterase was measured 30 minutes after ALP administration in groups 2 and 3, and 60 minutes later in group 4. Just before gaining consciousness the incision was closed. The animals were then monitored for evaluation of health status for 1 week as a recovery phase.

The samples for cholinesterase activity were collected into test tubes and centrifuged (4500 rpm for 5 min) at room temperature. The supernatants were separated and were stored at −20°C until being analyzed. Cholinesterase activity in the supernatant was measured spectrophotometrically at 405 nm using an auto analyzer (Hitachi-902, Hitachinaka, Japan) following Pars Azmun kit instructions.

Drugs

ALP (phostoxin, 3 mg tablet, ALP 56%, w/w) was from Shanghai AgroChina International Co. Ltd., China.

Sweet almond oil, 60 ml/bottle, Kimia Pack Co., Karaj, Iran.

Statistics

The survival times of different groups were compared using Log Rank method of Kaplan-Meier analysis. The p value of less than 0.05 was considered significant. All analyses were done using SPSS V.16. Survival times of different groups were noted using estimated means (minutes) ±standard error (SEM).

Results

All the animals in group 1 survived and all in group 2 died. The mean survival time of rats exposed to ALP without any intervention was 101.1 ± 1.4 minutes (min). In the intoxicated rats which were given sweet almond oil immediately after poisoning (group 3), 4 rats survived and among the dead ones only one could live for 22 hours, with others being dead with maximum survival time of 200 min. The mean survival time for rats of group 3 was 4250.50 ± 1508 min. In group 4, the one with delayed intervention, the mean survival time was 1364.10 ± 933.03 min and one rat survived. Here in group 4, among 9 dead rats, 2 animals could live for 23 and 24 hours with others being dead of which the maximum survival time was 120 min (Figure 1 ). In analysis of survival times, There was a significant difference between group 2 which received ALP and the groups which underwent intervention (groups 2 and 3, p < 0.001; groups 2 and 4, p = 0.007). We also found that the mean survival time in animals received oil immediately, was markedly higher than the group 4 with delayed intervention (p = 0.049).

Figure 1.

Survival curves of four study groups.

Mean cholinesterase levels (units/liter; U/L) were measured; group 1: 760 ± 32 U/L; group 2: 425 ± 30 U/L; group 3: 650 ± 30 U/L; group 4: 470 ± 20 U/L. Significant reduction in plasma cholinesterase activity for about 45% in group 2 and about 40% in group 4 were observed (Mann-Whitney U test, p < 0.01). There was no significant difference between inhibition of cholinesterase activity in groups 2 and 4 (Mann-Whitney U test, p = 0.191). On the other hand, the difference between reduced levels of cholinesterase were significant in groups 2 and 3 (Mann-Whitney U test, p = 0.001) and in groups 3 and 4 (Mann-Whitney U test, p = 0.039). During observing the animals we saw over secretion in nose and airway passages as a common presentation in some rats which may reflect the cholinergic effects of phosphine.

Discussion

The present study has demonstrated that intragastric sweet almond oil could increase survival time of animals exposed to ALP. There have been a few case reports of survival in patients of ALP poisoning when they were treated with vegetable oils especially with coconut oil.^21,23 In one human exposure to 12 g oral ALP, coconut oil was used with favorable outcomes.²³ In one study it has been shown that the survivors following ALP ingestion had more severe vomiting and lower hypotension and metabolic acidosis than the nonsurvivors.²⁴ This indirectly implies the importance of decreasing the burden of chemicals and the rapid rate of gastric absorption in this kind of toxicity. As seen in the present study, the poisoned animals undergoing immediate intervention with sweet almond oil had better outcomes considering both mean survival time and complete survival rate. Although the role of oils in providing better outcomes in patients has been shown through previous studies, their mechanisms of action were not clear.²³

One possible mechanism of toxicity with ALP is inhibition of cholinesterase activity; Works by Potter et al.²⁵ and Pazynich et al.²⁶ showed that phosphine can inhibit cholinesterase. Phosphine is mainly consumed as an intermediary in organophosphorus chemistry. Work by Lawson et al.²⁷ suggested that phosphine or phosphine-derived chemicals may be working through production of organophosphines. For the first time, Mittra et al.²⁸ showed 40% survival rate of animals exposed to ALP by using atropine and pralidoxime chloride. They concluded cholinesterase inhibition as one of the underlying mechanisms for ALP intoxication. Noting a variety of survival times in our study reflects the presence of unknown mechanisms for ALP intoxication. As mentioned above in our study results, despite significant inhibition of cholinesterase activity (40%) in group 4 (p < 0.01), the difference between survival times in groups 2 and 4 was significant (p = 0.007) and survival rate was 10% compared to no survival in group 2 with shorter mean survival time of about 101.1 ± 1.4 min. Interestingly, it is obvious that although there was no significant difference between levels of plasma cholinesterase in these two groups (p = 0.191), we found favorable outcomes in the group which received ALP with sweet almond oil 30 min later (group 4). It should be noted that the reduction rate of plasma cholinesterase in group 3 was lower than the groups 2 and 4 and the difference was significant (group 2 and 3, p = 0.001; group 3 and 4, p = 0.039).Pointing at these measures indicates that the timing of intervention with almond oil may have a role in gastric phase of phosphine absorption. On the other hand, noting the mortality rate of about 60% in group 3 despite no significant decrease in cholinesterase activity implies that unknown mechanisms other than cholinesterase inhibition for phosphine poisoning should be taken into account. Although serum cholinesterase activity was measured in this study as the only possible and available laboratory marker, there was no intention to use the results for establishing the cause and effect relationship. However, there is no clear explanation why some animals had favorable outcomes despite significant reduction of cholinesterase activity and some animals with normal cholinesterase activity had disappointing outcomes. Oils may possibly act through different mechanisms: decreasing the aqueous fraction of gastric juice or covering the surface of chemicals and preventing their activation, or interfering with the enteral phase of metabolism or possible innate characteristics of one specific oil (its antioxidant role or effect on mucosal surfaces). Consistent with our previous findings in studies with the same same rat model, where coconut and castor oils could not result in motivating results, we think factor or factors other than oily nature of sweet almond oil seem to play a role in the treatment of ALP toxicity. Providing the animals with a vitamin E enriched substance or role of almond oil as a mucosal stabilizer could be a possible antidote effect. In conclusion, on the basis of above study we can conclude that we can consider sweet almond oil as an effective agent in lowering mortality rate in ALP poisoning but some extended trials will be needed to confirm the efficacy. On the other hand, although a cholinesterase inhibiting effect has been proposed for ALP, other mechanisms of toxicity in this setting should be considered.

Footnotes

Acknowledgement

We wish to thank Mr. Gholamreza Bayat for his technical assistance.

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

References

Mehrpour

Singh

Rice tablet poisoning: a major concern in Iranian population. Hum Exp Toxicol 2010; 29: 701–702.

Sharma

Oral aluminium phosphide poisoning. Indians Pediatr 1995; 32: 339–342.

Dua

Gill

KD.

Effect of aluminium phosphide exposure on kinetic properties of cytochrome oxidase and mitochondrial energy metabolism in rat brain. Biochim Biophys Acta 2004; 1674: 4–11.

Banjaj

Wasir

HS.

Epidemic aluminum phosphide poisoning in northern India. Lancet 1988; 1: 820–821.

Bartels

Brzak

Mendrala

Stott

WT.

Mechanistic aspects of the metabolism of 1,3-dichloropropene in rats and mice. Chem Res Toxicol 2000; 13: 1096–1102.

Singh

Dilawari

Vashist

Malhotra

Sharma

BK.

Aluminium phosphide ingestion. Br Med J 1985; 290: 1110–1111.

Khosla

Nand

Khosla

Aluminium phosphide poisoning. J Trop Med Hyg 1988; 91: 196–198.

Tripathy

Pandey

SK.

The effect of aluminium phosphide on the human brain: a histological study. Med Sci Law 2007; 47: 141–146.

Chugh

Dushyant

Ram S

Arora

Malhotra

KC.

Incidence and outcome of all poisoning in a hospital study. Indian J Med Res 1991; 94: 232–235.

10.

Singh

Singhi

Sood

Kumar

Walia

BN.

Changing pattern of childhood poisoning (1970-1989): experience of a large north Indian hospital. Indian Pediatr 1995; 32: 331–336.

11.

Moghadamnia

Abdollahi

An epidemiological study of poisoning in northern Islamic Republic of Iran. East Mediterr Health J 2002; 8: 88–94.

12.

Abder-Rahman

Battah

Ibraheem

Shomaf

el-Batainch

Aluminum phosphide fatalities, new local experience. Med Sci Law 2000; 40: 164–168.

13.

Shadnia

Sasanian

Allami

Hosseini

Ranjbar

Amini-Shirazi

. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol 2009; 28: 209–213.

14.

Siwach

Yadav

Arora

Dalal

Jagdish . Acute aluminum phosphide poisoning-an epidemiological, clinical and histopathological study. J Assoc Physicians India 1988; 36: 594–596.

15.

Anger

Paysant

Brousse

Le Normand

Develay

Gaillard

. Fatal aluminum phosphide poisoning. J Anal Toxicol 2000; 24: 90–92.

16.

Lall

Peshin

Mitra

Methemoglobinemia in aluminium phosphide poisoning in rats. Indian J Exp Biol 2000; 38: 95–97.

17.

Lall

Peshin

Seth

SD.

Acute poisoning: a ten years retrospective hospital based studies. Ann Natl Acad Med Sci 1994; 30: 35–39.

18.

Duenas

Perez-Castrillon

Cobos

Herreros

Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug. Am J Emerg Med 1999; 17: 219–220.

19.

Azad

Lall

Mittra

Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. Acta Pharmacol Sin 2001; 22: 298–304.

20.

Proudfoot

AT.

Aluminium and zinc phosphide poisoning. Clin Toxicol 2009; 47: 89–100.

21.

Goswami

Bindal

Sen

Gupta

Avasthi

Ram

BK.

Fat and oil inhibit phosphine release from aluminium phosphide—its clinical implication. Indian J Exp Biol 1994; 32: 647–649.

22.

World Medical Association. ‘WMA Statement on Animal Use in Biomedical Research’, http://www.wma.net/en/30publications/10policies/a18/index.html (accessed October 2006).

23.

Shadnia

Rahimi

Pajoumand

Rasouli

Abdollahi

Successful treatment of acute aluminium phosphide poisoning: possible benefit of coconut oil. Hum Exp Toxicol 2005; 24: 215–218.

24.

Singh

Wig

Jit

Sharma

BK.

Aluminium phosphide ingestion-A clinico-pathologic study. J Toxicol Clin Toxicol 1996; 34: 703–706.

25.

Potter

Garry

Kelly

Tarone

Griffith

Nelson

RL.

Radiometric assay of red cell and plasma cholinesterase in pesticide applier from Minnesota. Toxicol Appl Pharmacol 1993; 119: 150–155.

26.

Pazynich

Mazur

Podloznyi

AV.

Experimental substantiation and prediction of time-related maximum permissible concentration of phosphine in the air. Gigiena i Sanitariia 1984; 1: 13–15.

27.

Lawson

Lieske

Fox-Talbot

Meyer

HG.

Spontaneous reactivation of phophinylated human erythrocyte acetylcholinesterase and human serum butyrylcholinesterase. Life Sci 1985; 36: 1715–1720.

28.

Mittra

Peshin

Lall

SB.

Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride. Acta Pharmacol Sin 2001; 22: 37–39.